Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAIV-T vaccine in healthy children (6-36 months)
NCT00192244Phase 3Completed
- Sponsor
- MedImmune
- Start
- Sep 2000
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of live attenuated influenza vaccine in influenza, sponsored by MedImmune. Started Sep 2000; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00192244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192244.